- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Respiratory Microbiome may have Protective Role Against Long COVID, suggests study

A study published in Microbiology Spectrum has revealed that certain naturally occurring respiratory bacteria may help protect against long COVID. Higher levels of Dolosigranulum pigrum and Corynebacterium species in the upper respiratory tract were associated with a lower risk of developing post-acute sequelae of SARS-CoV-2 (PASC). The findings suggest that variations in nasal microbiome composition may influence the severity and long-term outcomes of COVID-19. The study was conducted by Bradley W. and colleagues.
The nasopharynx is the first entry point for respiratory viruses, but the function of the indigenous bacteria during the prolonged stage of COVID-19 infection was not well understood. Therefore, this study attempted to examine the variations in the microbiome structure in patients with different clinical manifestations of COVID-19 and its changes during recovery from infection. To provide a complete evaluation of the phenomenon, the authors selected a varied group consisting of 156 people.
The sample consisted of 25 control subjects, 24 influenza patients, and 107 patients with COVID-19, including 50 with moderate disease and 57 with severe disease. The samples were taken using nasopharyngeal swabs at two crucial stages, namely during the acute infection and 3 months after the infection resolution. The authors used the shotgun metagenomics approach to perform a detailed examination of the microbiome at the species level. Alpha and beta diversity analysis combined with differential abundance analysis allowed us to monitor the changes in the bacterial population.
Key findings:
From the analysis, it became apparent that the appearance of "protector" species was highly dependent on the clinical treatment in the acute phase.
Particularly, the consumption of antibiotics was found to be correlated with decreased abundance of "protector" species, thereby potentially enhancing one’s vulnerability to PASC in cases where the body is invaded by another superinfection.
In a group of 107 patients who suffered from COVID-19 infection, it became evident that the patients with high levels of D. pigrum and Corynebacterium recovered more effectively.
The longitudinal monitoring for the course of three months proved that although there were many changes within the microbiome, the deficiency of beneficial bacteria was a distinctive feature of PASC syndrome.
The study shows that there is a certain change in the respiratory microbiome that is directly related to the overall recovery process of people infected with COVID-19. It should be noted that the preservation or restoration of balance in the respiratory microbiome can prevent the occurrence of persistent signs of this infection, which in turn means reducing the likelihood of getting PASC. Through understanding which bacteria in the microbiome decrease in numbers in people suffering from Long COVID, researchers have discovered a potential biomarker for risk, along with a new point of intervention.
Reference:
Ward B, Bindels LB, Balligand J, Bearzatto B, Bommer G, Cani PD, De Greef J, Dewulf JP, Gatto L, Haufroid V, Jodogne S, Kabamba B, Pyr dit Ruys S, Vertommen D, Yombi JC, Belkhir L, Elens L. 2026. Association of nasopharyngeal Dolosigranulum pigrum and Corynebacterium species with post-acute sequelae of SARS-CoV-2 in a longitudinal cohort. Microbiol Spectr 14:e02313-25.
https://doi.org/10.1128/spectrum.02313-25
Dr Riya Dave has completed dentistry from Gujarat University in 2022. She is a dentist and accomplished medical and scientific writer known for her commitment to bridging the gap between clinical expertise and accessible healthcare information. She has been actively involved in writing blogs related to health and wellness.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

